Scavilla Daniel T 4

What Happened
Daniel T. Scavilla, President, CEO and Director of DENTSPLY SIRONA Inc. (XRAY), was granted 3,554.869 phantom shares on 2026-03-11. The grant is reported at $11.43 per share, with a total economic value of approximately $40,632. This was an award (derivative/phantom stock) under a supplemental executive retirement plan (SERP), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-11; Filing date: 2026-03-12 (timely filing).
• Transaction type/code: A — Award/Grant of phantom stock.
• Quantity & price: 3,554.869 phantom shares @ $11.43 = ~$40,632.
• Shares owned after transaction: Not specified in the filing.
• Footnotes:
  • F1/F2 — Each phantom share equals the economic equivalent of one common share and the grant is comprised of phantom stock; payout in common stock occurs upon termination of employment.
  • F3 — This represents a SERP contribution for 2025 based on the 12/31/2025 closing price.
• Implication for investors: This is compensation-based (routine award) and does not reflect an open-market buy or sell decision by the insider.

Context: Phantom stock is a derivative compensation vehicle that tracks the value of common shares; it typically pays out in cash or stock upon a triggering event (here, termination of employment). Such awards are routine executive compensation and should be interpreted differently than outright purchases or sales.